Skip to main content

Table 1 Risk group classification for localized prostate cancer according to the National Comprehensive Cancer Network guidelines

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

  T Stage PSA (ng/ml) Gleason score
(Very) low risk T1–T2a < 10 2–6
Intermediate risk T2b-c 10–20 7
(Very) high risk T3a-b >20 8–10